Phase 1 N=18 The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets
Influenza
Primary: HAI Titers
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=100 Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions
Peripheral Arterial Disease
Primary: Freedom From Clinically-driven TLR at 12 Months — 5 participants
Phase 1 N=24 Piperaquine Granule Formulation Relative Bioavailability and Food Effect Study in Healthy Volunteers.
Malaria
Primary: Relative Bioavailability (Frel) of the Maximum Observed Plasma Concentration (Cmax) of the PQP Dispersible Granule Compared to the PQP Hard Tablet in the Fasted State…
N/A N=158 RCT Social Cognition Training and Therapeutic Alliance Focused Therapy for Persons With Severe Mental Illness
Mental Disorders
Primary: The Face Emotion Identification Task (FEIT) — 12.83; 12.47; 11.55; 13.65 score on a scale
Phase 2 N=389 A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression
Depressive Disorder, Major
Primary: Change From Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score at Week 6 — -13.0; -12.4; -10.8; -10.8 Units on a scale — p=0.7636
N/A N=95 Investigation of the Effects of a Bifidobacterium Breve Strain on Fat Loss in Healthy Adults
Obesity · Overweight and Obesity
Primary: Change in Fat Loss (g) — -78.38; -9.43 g
N/A N=62 Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair
Full Thickness Rotator Cuff Tear
Primary: American Shoulder and Elbow Surgeons (ASES) Score — 87; 89 score on a scale
Phase 3 N=91 OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)
Hereditary Angioedema
Primary: Time-Normalized Investigator-Confirmed (IC) HAE Attack Rate (Per Month) From Week 1 to Week 25 — 2.26; 0.44; 1.02 HAE attacks per month — p=<0.001
N/A N=164 Information Visualizations to Enhance HIV-related Communication
HIV · Communication Research
Primary: Change in CD4 Count Over Time — 446.71; 453.99; 498.04; 537.90 Cells/mm3 — p=.455
N/A N=120 CorPath® GRX Neuro Study
Intracranial Aneurysm · Subarachnoid Hemorrhage · Headache
Primary: Number of Participants With Procedural Technical Success. — 110 Participants
N/A N=102 Clinical Performance and Cost Effectiveness of Biatain® Silicone Compared With Standard of Care
Venous Leg Ulcer · Diabetic Foot Ulcer
Primary: Percentage Wound Area Reduction (WAR) During Four Weeks — 43; 54.3 Percentage of wound area reduction
N/A N=558 Comparison of Full-Field Digital Mammography With Digital Breast Tomography for Screening Call-Back Rates
Breast Neoplasms
Primary: Recall Rate in Group A Participants — 29; 34; 472; 467 Participants — p=0.46
Phase 1 N=32 Safety and Efficacy of R0.6C Vaccine
Malaria · Malaria,Falciparum
Primary: Number of Serious Adverse Events and Grade 3 Adverse Events — 0; 0; 0; 0 adverse events
Phase 2 N=26 Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC
Squamous Cell Carcinoma of the Head and Neck (SCCHN) · Recurrent Squamous Cell Carcinoma of the Head and Neck · Metastatic Head and Neck Cancer
Primary: Best Overall Response (BOR) Rate — 0.19 proportion of participants
N/A N=130 Comparison Between End-to-side and Side-to-side Anastomosis After Laparoscopic Right Hemicolectomy
Anastomosis
Primary: Cumulative Recovery Rate — 100; 100 percentage of participants